Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Expects COVID-19 Vaccines To Meet ‘EUA Plus’ Standards, Marks Says

Sep 11 2020

• By Derrick Gingery

Doctor, nurse, scientist hand in blue gloves holding flu, measles, coronavirus, covid-19 vaccine disease preparing for child, baby, adult, man and woman vaccination shot, medicine and drug concept. — CBER Director Peter Marks indicated that more guidance on the emergency use authorization process may be released soon. • Source: Shutterstock

Related Content

Coronavirus Vaccine Efficacy Rate Set At 50% Because That’s What US FDA ‘Could Tolerate’

Jul 09 2020

CBER’s ‘Courageous’ Coronavirus Guidance Strategy May Catch-On

Jun 26 2020

COVID-19 Vaccine Should Demonstrate At Least 50% Effectiveness, US FDA Says

Jul 01 2020

COVID-19 Vaccine Advisory Committee May Help Determine US FDA Approach To Licensure

Aug 28 2020

COVID-19 Vaccine Sponsors’ Pledge To Wait For Phase III Helps US FDA

Sep 09 2020

Gottlieb: Staged Access To Coronavirus Vaccine Possible Through EUA

Sep 08 2020

Additional Topics

United States Coronavirus COVID-19 Vaccines Review Pathway Regulation Drug Review FDA BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window